Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)
Japan flag Japan · Delayed Price · Currency is JPY
49.00
0.00 (0.00%)
Nov 18, 2026, 10:29 AM JST

TYO:4596 Income Statement

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12.772127398-
Revenue Growth
-54.84%-22.22%-30.77%387.50%-78.38%-
Cost of Revenue
23.09265125-
Gross Profit
-10.33-522273-
Selling, General & Admin
600.91543711633602604
Research & Development
524.753105437881,5122,040
Other Operating Expenses
-21.96-1110--
Operating Expenses
1,1048531,2551,5312,1142,644
Operating Income
-1,114-858-1,233-1,504-2,111-2,644
Interest Expense
---7-9-11-18
Interest & Investment Income
2.8915131811
Other Non Operating Income (Expenses)
217.2121715118935
EBT Excluding Unusual Items
-893.93-640-1,220-1,489-2,015-2,616
Gain (Loss) on Sale of Assets
---56---
Asset Writedown
-36-36-56---
Other Unusual Items
-217.87-----
Pretax Income
-1,148-676-1,332-1,489-2,015-2,616
Net Income
-1,148-676-1,332-1,489-2,015-2,616
Net Income to Common
-1,148-676-1,332-1,489-2,015-2,616
Net Income Growth
------
Shares Outstanding (Basic)
1256456564946
Shares Outstanding (Diluted)
1256456564946
Shares Change
107.76%13.32%1.35%12.85%8.19%6.30%
EPS (Basic)
-9.17-10.59-23.64-26.78-40.90-57.45
EPS (Diluted)
-9.18-10.59-23.65-26.79-40.92-57.46
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-933.6-593-1,244-1,401-2,143-2,521
Free Cash Flow Per Share
-7.46-9.29-22.08-25.20-43.50-55.36
Gross Margin
-80.88%-23.81%81.48%69.23%37.50%-
Operating Margin
-8727.18%-4085.71%-4566.67%-3856.41%-26387.50%-
Profit Margin
-8991.77%-3219.05%-4933.33%-3817.95%-25187.50%-
Free Cash Flow Margin
-7313.71%-2823.81%-4607.41%-3592.31%-26787.50%-
EBITDA
--793-1,168-1,417-2,053-2,585
D&A For EBITDA
-6565875859
EBIT
-1,114-858-1,233-1,504-2,111-2,644